Ribocation transition state capture and rebound in human purine nucleoside phosphorylase. 2009

Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461, USA.

Purine nucleoside phosphorylase (PNP) catalyzes the phosphorolysis of 6-oxy-purine nucleosides to the corresponding purine base and alpha-D-ribose 1-phosphate. Its genetic loss causes a lethal T cell deficiency. The highly reactive ribocation transition state of human PNP is protected from solvent by hydrophobic residues that sequester the catalytic site. The catalytic site was enlarged by replacing individual catalytic site amino acids with glycine. Reactivity of the ribocation transition state was tested for capture by water and other nucleophiles. In the absence of phosphate, inosine is hydrolyzed by native, Y88G, F159G, H257G, and F200G enzymes. Phosphorolysis but not hydrolysis is detected when phosphate is bound. An unprecedented N9-to-N3 isomerization of inosine is catalyzed by H257G and F200G in the presence of phosphate and by all PNPs in the absence of phosphate. These results establish a ribocation lifetime too short to permit capture by water. An enlarged catalytic site permits ribocation formation with relaxed geometric constraints, permitting nucleophilic rebound and N3-inosine isomerization.

UI MeSH Term Description Entries
D007288 Inosine A purine nucleoside that has hypoxanthine linked by the N9 nitrogen to the C1 carbon of ribose. It is an intermediate in the degradation of purines and purine nucleosides to uric acid and in pathways of purine salvage. It also occurs in the anticodon of certain transfer RNA molecules. (Dorland, 28th ed)
D007536 Isomerism The phenomenon whereby certain chemical compounds have structures that are different although the compounds possess the same elemental composition. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Isomerisms
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011683 Purine-Nucleoside Phosphorylase An enzyme that catalyzes the reaction between a purine nucleoside and orthophosphate to form a free purine plus ribose-5-phosphate. EC 2.4.2.1. Inosine Phosphorylase,Nicotinamide Riboside Phosphorylase,Purine Nucleoside Phosphorylases,Nucleoside Phosphorylases, Purine,Phosphorylase, Inosine,Phosphorylase, Nicotinamide Riboside,Phosphorylase, Purine-Nucleoside,Phosphorylases, Purine Nucleoside,Purine Nucleoside Phosphorylase,Riboside Phosphorylase, Nicotinamide
D011684 Purine Nucleosides Purines with a RIBOSE attached that can be phosphorylated to PURINE NUCLEOTIDES. Purine Nucleoside,Nucleoside, Purine,Nucleosides, Purine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D012267 Ribosemonophosphates Ribose substituted in the 1-, 3-, or 5-position by a phosphoric acid moiety.
D055162 Biocatalysis The facilitation of biochemical reactions with the aid of naturally occurring catalysts such as ENZYMES.

Related Publications

Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
March 2010, Proceedings of the National Academy of Sciences of the United States of America,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
February 2008, Biochemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
May 2007, Biochemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
December 2010, The journal of physical chemistry. B,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
November 2003, Journal of medicinal chemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
July 2003, Journal of medicinal chemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
January 2008, Journal of the American Chemical Society,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
June 2009, Biochemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
February 2002, The Journal of biological chemistry,
Mahmoud Ghanem, and Andrew S Murkin, and Vern L Schramm
June 1998, Biochemistry,
Copied contents to your clipboard!